6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neuroinflammation and Substance Use Disorders
Neuroinflammation refers to inflammation in the brain, which can be triggered by chronic substance use. This inflammation plays a significant role in the development and progression of substance use disorders by altering neural signaling, neurotransmitter systems, and brain structure. Persistent neuroinflammation can lead to cognitive deficits, emotional dysregulation, and a heightened susceptibility to addiction. Recent research suggests that targeting neuroinflammation may be a promising avenue for addiction treatment, as reducing inflammation could potentially reverse some of the cognitive and emotional impairments caused by substance use. Anti-inflammatory treatments, alongside traditional therapies, may provide new hope for individuals struggling with addiction.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States